8101 - 8150 of 8620 Results
Title
Year
-
OPENTitle: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patientsJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 7Issue #: 10Start Page: 1816End Page: 1830Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51164Best OA location URL: https://escholarship.org/uc/item/492590bjCitation Count: 38
-
OPENTitle: Clinical and Genetic Analysis of Costa Rican Patients With Parkinson's DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fneur.2021.656342Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.656342/pdfCitation Count: 6
- A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia2019RESTRICTEDTitle: A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystoniaJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 195End Page: 198Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.035Citation Count: 25
- Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson’s disease2022OPENTitle: Heterogeneous digital biomarker integration out-performs patient self-reports in predicting Parkinson’s diseaseJournal Name: Communications BiologyPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s42003-022-03002-xBest OA location URL: https://www.nature.com/articles/s42003-022-03002-x.pdfCitation Count: 27
- Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseases2015OPENTitle: Oligomeric α‐synuclein and β‐amyloid variants as potential biomarkers for Parkinson's and Alzheimer's diseasesJournal Name: European Journal of NeurosciencePublisher: WileyVol: 43Issue #: 1Start Page: 3End Page: 16Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ejn.13056Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ejn.13056Citation Count: 68
-
RESTRICTEDTitle: Design considerations for C9orf72 disease prevention trialsJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf290Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf290/63960980/awaf290.pdfCitation Count: 0
- Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference2025OPENTitle: Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global ConferenceJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.70078Best OA location URL: https://doi.org/10.1002/alz.70078Citation Count: 0
-
OPENTitle: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0245-9Best OA location URL: https://doi.org/10.1186/s13024-018-0245-9Citation Count: 65
- Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s Disease2022OPENTitle: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s DiseaseJournal Name: JACS AuPublisher: American Chemical Society (ACS)Vol: 2Issue #: 9Start Page: 2013End Page: 2022Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/jacsau.2c00300Best OA location URL: https://doi.org/10.1021/jacsau.2c00300Citation Count: 31
- Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's Disease2022OPENTitle: Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2257End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29189Citation Count: 21
- Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagus2015OPENTitle: Functional segregation of voltage-activated calcium channels in motoneurons of the dorsal motor nucleus of the vagusJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 3Start Page: 1513End Page: 1520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00432.2014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4561632Citation Count: 19
- Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivo2021OPENTitle: Preclinical modeling of chronic inhibition of the Parkinson’s disease associated kinase LRRK2 reveals altered function of the endolysosomal system in vivoJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00441-8Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00441-8Citation Count: 46
-
OPENTitle: A connectomics-based taxonomy of mammalsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.78635Best OA location URL: https://doi.org/10.7554/elife.78635Citation Count: 25
- The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status2021OPENTitle: The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier statusJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00778-8Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-021-00778-8Citation Count: 54
-
OPENTitle: PINK1 regulated mitophagy is evident in skeletal musclesJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1080/27694127.2024.2326402Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2024.2326402?needAccess=trueCitation Count: 11
-
OPENTitle: Data Archive for the BRAIN Initiative (DABI)Journal Name: Scientific DataPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41597-023-01972-zBest OA location URL: https://www.nature.com/articles/s41597-023-01972-z.pdfCitation Count: 15
-
OPENTitle: Multimodal assessment of nigrosomal degeneration in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 80Issue #:Start Page: 102End Page: 107Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.09.021Best OA location URL: https://arxiv.org/pdf/2009.01378Citation Count: 17
- International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease2021OPENTitle: International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2583End Page: 2594Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28706Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28706Citation Count: 104
- Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stress2024OPENTitle: Tom20 gates PINK1 activity and mediates its tethering of the TOM and TIM23 translocases upon mitochondrial stressJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2313540121Best OA location URL: https://doi.org/10.1073/pnas.2313540121Citation Count: 31
-
OPENTitle: Alzheimer's disease traits in Parkinson's disease without α‐synuclein seedingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.70284Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70284Citation Count: 0
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0
-
OPENTitle: Genome-wide association study and functional validation implicates JADE1 in tauopathyJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 143Issue #: 1Start Page: 33End Page: 53Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-021-02379-zBest OA location URL: https://escholarship.org/content/qt1qc6t64s/qt1qc6t64s.pdfCitation Count: 32
- Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features2023OPENTitle: Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic featuresJournal Name: Physica MedicaPublisher: Elsevier BVVol: 113Issue #:Start Page: 102647End Page: 102647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2023.102647Citation Count: 9
-
OPENTitle: Regulation of LRRK2 activity by metabolic stress and heavy metal exposureJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1863Issue #:Start Page: 149785End Page: 149785Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2025.149785Best OA location URL: https://doi.org/10.1016/j.brainres.2025.149785Citation Count: 0
- Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patients2015OPENTitle: Identification of rare protein disulfide isomerase gene variants in amyotrophic lateral sclerosis patientsJournal Name: GenePublisher: Elsevier BVVol: 566Issue #: 2Start Page: 158End Page: 165Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.gene.2015.04.035Best OA location URL: https://repositorio.uchile.cl/handle/2250/133590Citation Count: 73
- Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model2021OPENTitle: Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse modelJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 6Start Page: e0252325End Page: e0252325Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0252325Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0252325&type=printableCitation Count: 31
- Functional selectivity induced by mGlu4 receptor positive allosteric modulation and concomitant activation of Gq coupled receptors2012OPENTitle: Functional selectivity induced by mGlu4 receptor positive allosteric modulation and concomitant activation of Gq coupled receptorsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 66Issue #:Start Page: 122End Page: 132Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2012.03.003Citation Count: 13
- A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells2023OPENTitle: A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed CellsJournal Name: Angewandte ChemiePublisher: WileyVol: 135Issue #: 40Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ange.202309306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202309306Citation Count: 0
- Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician Interviews2019OPENTitle: Barriers and facilitators of communication about off periods in Parkinson’s disease: Qualitative analysis of patient, carepartner, and physician InterviewsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 14Issue #: 4Start Page: e0215384End Page: e0215384Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0215384Best OA location URL: https://doi.org/10.1371/journal.pone.0215384Citation Count: 32
-
OPENTitle: Circular RNAs in the human brain are tailored to neuron identity and neuropsychiatric diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-40348-0Best OA location URL: https://www.nature.com/articles/s41467-023-40348-0.pdfCitation Count: 37
- Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error rates2023OPENTitle: Seed amplification assay results illustrate discrepancy in Parkinson’s disease clinical diagnostic accuracy and error ratesJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 270Issue #: 12Start Page: 5813End Page: 5818Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-023-11810-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00415-023-11810-2.pdfCitation Count: 6
-
OPENTitle: Exploring variability in basal ganglia connectivity with functional MRI in healthy agingJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 12Issue #: 6Start Page: 1822End Page: 1827Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11682-018-9824-1Best OA location URL: https://link.springer.com/content/pdf/10.1007%2Fs11682-018-9824-1.pdfCitation Count: 21
-
OPENTitle: Parkin interacting substrate phosphorylation by c-Abl drives dopaminergic neurodegenerationJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 144Issue #: 12Start Page: 3674End Page: 3691Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab356Best OA location URL: https://academic.oup.com/brain/article-pdf/144/12/3674/42004692/awab356.pdfCitation Count: 21
- A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial Changes2019OPENTitle: A Systems-Based Map of Human Brain Cell-Type Enriched Genes and Malignancy-Associated Endothelial ChangesJournal Name: Cell ReportsPublisher: Elsevier BVVol: 29Issue #: 6Start Page: 1690End Page: 1706.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2019.09.088Best OA location URL: http://www.cell.com/article/S2211124719312926/pdfCitation Count: 30
- Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain2024OPENTitle: Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brainJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00830-yBest OA location URL: https://doi.org/10.1038/s41531-024-00830-yCitation Count: 1
-
RESTRICTEDTitle: Correlations between CSF proteins and spontaneous neuronal activity in Parkinson’s diseaseJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 673Issue #:Start Page: 61End Page: 66Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2018.02.062Citation Count: 6
- Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers2015RESTRICTEDTitle: Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriersJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 83Issue #:Start Page: 115End Page: 121Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.08.011Citation Count: 142
- An Enhanced Mountain Climbing Search Algorithm to Enable Fast and Accurate Autofocusing in High Resolution Fluorescence Microscopy2025RESTRICTEDTitle: An Enhanced Mountain Climbing Search Algorithm to Enable Fast and Accurate Autofocusing in High Resolution Fluorescence MicroscopyJournal Name: Methods and Applications in FluorescencePublisher: IOP PublishingVol: 13Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1088/2050-6120/ae008fBest OA location URL: https://iopscience.iop.org/article/10.1088/2050-6120/ae008f/pdfCitation Count: 0
-
OPENTitle: Loss of α-Synuclein Does Not Affect Mitochondrial Bioenergetics in Rodent NeuronsJournal Name: eneuroPublisher: Society for NeuroscienceVol: 4Issue #: 2Start Page: ENEURO.0216End Page: 16.2017Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0216-16.2017Best OA location URL: https://escholarship.org/content/qt87h1c8db/qt87h1c8db.pdfCitation Count: 15
- NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation2022OPENTitle: NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome ActivationJournal Name: International Journal of InflammationPublisher: WileyVol: 2022Issue #:Start Page: 1End Page: 12Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/2337363Best OA location URL: https://downloads.hindawi.com/journals/iji/2022/2337363.pdfCitation Count: 6
-
RESTRICTEDTitle: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 196End Page: 200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28805Citation Count: 27
- Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO Proteins2018OPENTitle: Comparative Protein Interaction Network Analysis Identifies Shared and Distinct Functions for the Human ROCO ProteinsJournal Name: PROTEOMICSPublisher: WileyVol: 18Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/pmic.201700444Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pmic.201700444Citation Count: 44
- D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats2017OPENTitle: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian ratsJournal Name: British Journal of PharmacologyPublisher: WileyVol: 174Issue #: 18Start Page: 3058End Page: 3071Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bph.13937Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5573415Citation Count: 23
- Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson’s disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicity2020OPENTitle: Genome-wide epigenetic analyses in Japanese immigrant plantation workers with Parkinson’s disease and exposure to organochlorines reveal possible involvement of glial genes and pathways involved in neurotoxicityJournal Name: BMC NeurosciencePublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12868-020-00582-4Best OA location URL: https://bmcneurosci.biomedcentral.com/track/pdf/10.1186/s12868-020-00582-4Citation Count: 28
- Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates2020OPENTitle: Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primatesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 5Start Page: 1462End Page: 1475Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awaa096Best OA location URL: https://academic.oup.com/brain/article-pdf/143/5/1462/33470596/awaa096.pdfCitation Count: 178
-
OPENTitle: Distinct AQP4 Alterations in Movement Disorders with Primary SynucleinopathyJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70023Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdf/10.1002/mds.70023Citation Count: 0
- Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In Vitro2020OPENTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 14Issue #: 6Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866Best OA location URL: https://ndownloader.figstatic.com/files/22969427Citation Count: 14
- Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies2013OPENTitle: Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 453Issue #: 1Start Page: 101End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bj20121742Best OA location URL: https://portlandpress.com/biochemj/article-pdf/453/1/101/675176/bj4530101.pdfCitation Count: 94
-
OPENTitle: Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00502-3Best OA location URL: https://www.nature.com/articles/s41531-023-00502-3.pdfCitation Count: 8
-
OPENTitle: Neuroimaging and clinical predictors of fatigue in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 23Issue #:Start Page: 45End Page: 49Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.11.029Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.11.029Citation Count: 36